Sandoz International GmbH

Type: Subsidiary
On the web: http://www.sandoz.com

Sandoz makes over 5,000 different doses of generic pharmaceuticals and biotechnological drugs. As the generics arm of Swiss drug firm Novartis AG, Sandoz develops products including antibiotics and hormone therapies, as well as treatments for cardiovascular, central nervous system, and gastrointestinal disorders. Sandoz produces finished dosage forms of such off-patent drugs as Duragesic (Fentanyl) and GERD drug Prilosec. It also develops active pharmaceutical ingredients used by other companies to form finished products. Beyond the more common tablet form generics, Sandoz manufactures more complex generics in different delivery systems including patches and inhalers.

Officers:
CEO: Andreas Rummelt
CFO: Kevin Plummer
Head, Communications and Public Affairs: Kurt Leidner

Competitors:
Forest Labs
Teva Pharmaceuticals
Watson Pharmaceuticals